Skip to main content
Veterinary Medicines

Calcipharm PMD Solution for Injection

Not authorised
  • Glucose monohydrate
  • Boric acid
  • Calcium gluconate
  • Magnesium hypophosphite hexahydrate

Product identification

Medicine name:
Calcipharm PMD Solution for Injection
Active substance:
  • Glucose monohydrate
  • Boric acid
  • Calcium gluconate
  • Magnesium hypophosphite hexahydrate
Target species:
  • Sheep
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Glucose monohydrate
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Boric acid
    34.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium gluconate
    166.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium hypophosphite hexahydrate
    85.97
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
  • Subcutaneous use
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • 400 ml Type III glass vial (amber) sealed with rubber (black) wad and aluminium screw cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chem-Pharm
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
Responsible authority:
  • HPRA
Authorisation number:
  • VPA10823/014/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download